Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 12, 2024 16:05 ET
|
Fractyl Health, Inc.
REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025
Peptide Therapeutics Market Size to Surpass USD 76.11 Billion by 2033 | Straits Research
November 11, 2024 10:10 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Researchers have used peptides to deliver drugs to target cells due to their remarkable efficacy and selectivity towards the different...
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
October 28, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
E-Star BioTech Set to Initiate Phase 2 Clinical Trial of MANP in Resistant Hypertension With Support of Latest Investment
October 08, 2024 09:00 ET
|
E-Star Biotech
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney...
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
September 24, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
Peptide Therapeutics Market Size is Expected to Reach USD 85.9 billion, Advancing at a CAGR of 9.6% by 2031: Transparency Market Research Inc.
September 04, 2024 09:43 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The global peptide therapeutics market (ペプチド治療薬市場) is estimated to thrive at a CAGR of...
Fractyl Health to Participate in Upcoming September Investor Conferences
September 03, 2024 07:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Participate in Upcoming September Investor Conferences
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 14, 2024 16:05 ET
|
Fractyl Health, Inc.
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
[Latest] Global Epigenetics Diagnostic Market Size/Share Worth USD 41.6 Billion by 2033 at a 14.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 23, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, July 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Epigenetics Diagnostic Market Size, Trends and Insights By Product Type...
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
May 24, 2024 19:45 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., May 24, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based...